Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Boundless boldly goes public with $100M IPO
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024.
James Waldron
Mar 28, 2024 7:10am
GAO: FDA should audit hiring efforts to boost worker retention
Mar 27, 2024 4:15pm
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
Moderna touts 3 phase 1 data sets to bolster early vax work
Mar 27, 2024 3:21pm
Sponsored
Cognizant & Takeda Discuss Digital Transformation in Lifescience
Feb 12, 2024 8:00am
Nymox CEO calls ex-staffers' rebellion 'transparent mischief'
Mar 27, 2024 11:12am